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COVID-19: On the quarantine duration after
short visits to high-risk regions
Evangelos Matsinos
Abstract
A simple Monte-Carlo method will be put forward herein, to enable the extraction of
an estimate for the quarantine duration, applicable to visitors to high-risk regions.
Results will be obtained on the basis of an analysis of the upper tail of the cumulative
distribution function of the time span between the departure of the travellers from
the place where the infection occurs and the time instant when COVID-19 infections
may currently be detected. As expected, the quarantine duration is a decreasing
function of the fraction of the infected travellers, which one is prepared to identify
as ‘acceptable risk’. The analysis suggests that a maximal 5 % risk (of new infections
originating from subjects who become infective after their quarantine is lifted) may
be associated with a minimal quarantine duration of about eight days, 1 % with
about twelve, and 0.1 % with about sixteen. Unless the distribution of the duration
of short (typically, up to three weeks) travels departs significantly from the shape
assumed in this study, the results of the present analysis do not provide support for
the plans to shorten the quarantine duration of about ten days to two weeks, which
currently applies to travellers entering most European countries from regions with
a high risk of infection.
Key words: Epidemiology, infectious disease, mathematical modelling and
optimisation, COVID-19, SARS-CoV-2
1 Introduction
The advent of 2020 brought humanity to the era of the Coronavirus (COVID-
19) pandemia. This infectious disease, caused by the ‘Severe Acute Respiratory
Syndrome Coronavirus 2’ pathogen (SARS-CoV-2), poses a global threat to
the provision of basic medical care, as well as to economic growth. As Gita
Gopinath, the Economic Counsellor and Director of the Research Depart-
ment at the International Monetary Fund, wrote on April 14 in an article
entitled ‘The Great Lockdown: Worst economic downturn since the Great
Depression’: “This is a truly global crisis as no country is spared. Countries
reliant on tourism, travel, hospitality, and entertainment for their growth are
experiencing particularly large disruptions. Emerging market and developing
economies face additional challenges with unprecedented reversals in capital
flows as global risk appetite wanes, and currency pressures, while coping with
weaker health systems, and more limited fiscal space to provide support. More-
over, several economies entered this crisis in a vulnerable state with sluggish
growth and high debt levels.” [1]
To restrain the rapid dissemination of the disease, lockdowns were imposed
in most European countries and in the United States between March and
early June, as well as in several Asian countries somewhat earlier. By the end
of September, with over one million deceased worldwide (and counting), the
use of masks in enclosed spaces became mandatory, whereas the authorities
miss no opportunity to remind us of social distancing and attentiveness to
personal hygiene, in particular hand disinfection. The effort towards carrying
out tests on the verge of (what currently appears to be) the second wave of the
pandemia intensified, isolation and quarantine entered our daily vocabulary,
and contact-tracing applications were put in place to provide assistance in
combatting the ramifications of new infections.
As the economic aspects of the mitigation measures make front-page news,
another important issue is frequently underrated. Isolation, quarantine, and
distance-learning/remote-working practices are expected to have a more last-
ing impact on personalities which are in the early development phases, i.e., on
children and on adolescents. The elementary force in our society is the interac-
tion between the individuals. This interaction shapes our social conduct and
provides us with the necessary experience to cope with future situations aris-
ing in our dealings with other individuals or groups. Isolation, quarantine, and
distance learning for the children and the adolescents imply that their only
nonvirtual interactions are those with their immediate environment, presum-
ably with the family, which comprise their ‘already known’. The likelihood that
this ‘confinement within the known and alienation from the unknown’ might
leave an indelible mark upon the social competence of the minors should not
be underestimated.
This technical note relates to the duration of the quarantine for visitors to
high-risk regions. At this time, a quarantine of fourteen days applies to many
European travellers when they return home from such regions. In the early
phases of what appears to be the beginning of another critical period in rela-
tion to this disease, several European countries, i.e., the Netherlands, Norway,
and Switzerland, have in place (since a few months) a ten-day quarantine,
whereas other countries, e.g., Spain and Poland, plan on shifting to a quaran-
tine of the same duration. With over 30 000 deceased and rising numbers of
new infections for the last two months, France appears to vacillate between
policies, contemplating a seven-day quarantine. Germany has announced plans
to shorten the quarantine duration substantially, to five days, which accord-
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ing to virologist Christian Drosten would be “sufficient”. There are also those
who express disapproval of such plans, believing that “halving the quarantine
period would be negligent.” [2]
Quarantine currently applies to
a) visitors to high-risk regions, who subsequently travel to another destination,
b) subjects who have had a contact with a diagnosed or suspected case, and
c) subjects who have been diagnosed positive for COVID-19.
As aforementioned, this work pertains to case (a) above.
The goal herein is to investigate whether a simple procedure for determining
the quarantine duration could be established from known facts, as well as from
reasonable assumptions about the distribution of the duration of short travels,
i.e., of travels lasting up to three weeks. A straightforward Monte-Carlo (MC)
approach will be put forward as the most efficient manner to study such effects.
In this work, a test will be assumed to be reliable if its outcome is reproducible
and accurate. The effectiveness of a COVID-19 test will be associated with
the minimal viral load which is required for the confirmation of an infection.
In this respect, tests will become more effective in the future, as (compared
to the present time) they are expected to become capable of confirming an
infection on the basis of smaller viral loads. From now on, the use of the term
‘an effective COVID-19 test’ will refer to the most effective test available at
the time for the detection of a COVID-19 infection, which - in addition - yields
a reliable result within a few hours.
2 Method
The travel histories will be generated as follows.
• The duration of travel will be sampled from a rescaled beta distribution
between one and twenty-one days. The parameters of the beta distribution
will be selected in such a way as to place the average of the distribution
at about twelve days, which was the average duration of trips for German
travellers in 2019 [3].
• Each of the travellers will be infected at a random time instant during the
travel: three models will be followed. The probability of infection will be
assumed to be
(1) constant within the entire duration of each travel,
(2) increasing with time (i.e., from arrival to departure) according to a linear
model, and
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(3) increasing with time (i.e., from arrival to departure) according to a loga-
rithmic model.
The uniform model represents travellers who are equally attentive to the
observation of the precautions or of the mitigation measures throughout
their travel, whereas the linear and logarithmic models take account of the
psychological effect of habituation, i.e., of the reduction in one’s response to
a recurrent stimulus: it may be argued that, on average, the visitors tend to
be more attentive at the early stages of the travel, relaxing their attention
as time goes by (and ‘nothing happens’).
• The incubation interval for each subject will be sampled from a Weibull
distribution.
• The time instant at which each infected subject would test positive will be
randomly selected within the fraction of the incubation interval in which
the subject is believed to be infective (presymptomatic transmission).
The important time instants in each travel history are presented in diagram-
matic form in Fig. 1. One million travel histories, ramdomised by seeding
the random-number generator with the time of the start of each run, will be
generated per case, i.e.,
• for each method used in the sampling of the time instant of infection (Section
2.2) and
• for each of the three representative values of the only parameter of this work
(Section 2.4).
In this study, the unit of time is one day (d).
2.1 On sampling the duration of travel
My intention had first been to assume the broadest possible set of travellers,
taking no account of the gender, age, ethnicity, etc., of the type of travel (i.e.,
professional or recreational), and of the mode of transport. The ideal procedure
would be to acquire such data from several countries. However, the process of
obtaining the data would have been lengthy, as several authorities would have
to be contacted, would have to concur, and would have to communicate their
data in simple forms.
To provide a faster solution, the duration of travel was assumed to follow a beta
distribution, rescaled between one and twenty-one days. The beta distribution
is defined in the domain [0, 1]: 0 was mapped to one day and 1 was mapped
to three weeks. The parameter β of the beta distribution was set (arbitrarily)
to 2, whereas the parameter α ≈ 2.65 was chosen so that the average of the
resulting distribution would emerge at 12.4 days, which, according to Ref. [3],
was the average duration of travels for the German population in 2019.
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Fig. 1. The milestones in each travel history: the time instant t0 corresponds to the
arrival of the traveller at the location of infection; t1 represents the time instant
of infection; t2 marks the departure of the traveller from the location of infection,
taken (for the sake of simplicity) to be also the time instant of the arrival of the
traveller at the final destination; t3 represents the time instant when the traveller, if
tested via an effective COVID-19 test, would be found infected; finally, t4 represents
the onset of symptoms. The interval between the time instants t4 − r(t4 − t1) and
t4, shown highlighted in the figure, represents the time span within which the in-
fected subject may transmit the disease, though no symptoms have been developed
yet (presymptomatic transmission); t3 is randomly selected within the highlighted
interval.
Evidently, the MC generation also takes account of the short travels, which are
predominantly of a professional, rather than of a recreational, nature. Being
shorter, professional travels tend to generate infections closer to the departure
from the location of infection. Therefore, (in comparison with recreational
travellers) the professional travellers are expected (on average) to be found
infected at a later time after their arrival at the final destination.
2.2 On sampling the time instant of infection
I first thought that the sampling of the time instant of infection from a uni-
form distribution between the time instants t0 and t2 of Fig. 1 would suffice.
However, my intuition suggested that the effects of habituation should not
be ignored: one could argue that, facing an unknown setting, the travellers
tend to be cautious and attentive. As time goes by, experience is gained and
growing familiarity with the new setting may lead to the relaxation of the
attentiveness. Consequently, I decided to take account of such effects by in-
troducing two additional sampling methods: in the first, the time instant t1
will be sampled according to a linear model between t0 and t2 (probability of
infection linearly increasing with time from t0 to t2); in the second, t1 will be
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sampled from a logarithmic distribution.
The probability density function (PDF) of the linear model is given by
f(x) = 2
ax+ b
a+ 2b
, (1)
for x ∈ [0, 1]; x = 0 will be mapped to t0, x = 1 to t2. Without loss of
generality, it may be assumed that the parameters a and b satisfy: b > 0 and
a > −b; in addition, either a or b (but not both) may be equal to 0. (The
linear model reduces to the uniform distribution for a = 0.) The mean of the
distribution is given by
〈x〉 =
2a+ 3b
3(a+ 2b)
(2)
and its variance by
σ2 =
a2 + 6ab+ 6b2
18(a+ 2b)2
. (3)
The linear modelling admits one parameter, taken to be f(0). The quantity
2/f(0)−1 for f(0) 6= 0 is the ratio of the probabilities of infection at x = 1 and
x = 0. In the MC simulation, this parameter was set equal to 1/2, implying
that the infection at the end of the travel is three times more probable than
it was at the beginning.
The PDF of the logarithmic model is given by
f(x) = ca ln(ax+ b) , (4)
where
c =
(
ln
(
(a + b)a+b
bb
)
− a
)
−1
. (5)
The permissible parameter space is somewhat more complex than in case of
the linear model. The positivity of the various arguments of the logarithmic
function, as well as that of f(x) for x ∈ [0, 1], enforce the conditions: −b <
a ≤ 1 − b for 0 < b ≤ 1 and a ≥ 1 − b for b > 1. The value x = 0 will be
mapped to t0, x = 1 to t2. The mean of the distribution is given by
〈x〉 =
c
a

1
2
ln
(
(a+ b)(a+b)
2
bb2
)
− b ln
(
(a+ b)a+b
bb
)
−
a
4
(a− 2b)

 (6)
and its variance by
σ2 =
c
a2

1
3
ln
(
(a+ b)(a+b)
3
bb3
)
− b ln
(
(a+ b)(a+b)
2
bb2
)
+ b2 ln
(
(a+ b)a+b
bb
)
+
a
3
(
−
a2
3
+
ab
2
− b2
)− 〈x〉2 . (7)
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The logarithmic modelling admits two parameters, taken to be the ratios
f(1/2)/f(0) and f(1)/f(0). In the MC simulation, these parameters were set
equal to 2.5 and 3, respectively. This implies that the infection at the end
of the travel is three times more probable than it was at the beginning; and
that the infection halfway through the travel is 2.5 times more probable than
it was at the beginning. Therefore, in comparison with the linear model, the
probability of infection in the logarithmic model rises more steeply in the first
half of the travel interval (and more moderately in the second).
2.3 On sampling the incubation interval
The determination of the distribution of the incubation interval is detailed in
Appendix B. The results of the fit of the Weibull distribution to the available
data (see Table B.1) will be used in the MC generation.
2.4 On sampling the time instant when COVID-19 infections may currently
be detected
Although not corroborated (not necessarily refuted as well) by Ref. [4], let
me assume for the sake of the argument that the positivity of an effective
COVID-19 test is associated with a viral load ρpos, whereas the development of
symptoms is associated with a viral load ρons > ρpos. Assuming an exponential
growth, the viral load at time t after the infection satisfies: ρ(t) = ρ02
t/τ , where
τ (very likely, a subject-dependent quantity) is obviously the doubling time
of the virus. Evidently, the earliest time instant tpos for the positivity of the
test is: tpos = τ ln(ρpos/ρ0)/ ln(2). Similarly, the onset of symptoms occurs at
tons = τ ln(ρons/ρ0)/ ln(2). Therefore, tpos/tons = ln(ρpos/ρ0)/ ln(ρons/ρ0). In
this naive picture, the time span between the infection and the positivity of
the test is a constant fraction of the incubation interval.
The positivity of an effective COVID-19 test will be associated in this study
with the presymptomatic transmission, for which substantial evidence has
emerged [5,6,7,8,9,10,11,12]. The interval r(t4−t1), corresponding to the presymp-
tomatic transmission, is shown highlighted in Fig. 1, and (according to the
literature) it does not exceed a typical duration of two to four days. The time
instant t3 of Fig. 1 at which the subject is found infected will be randomly
selected within the interval r(t4 − t1). A linear model will be assumed when
sampling t3, increasing with time: this implies that the times close to the start
of the presymptomatic transmission (i.e., to the time instant t4− r(t4− t1) in
Fig. 1) will be given less weight (than subsequent time instances up to time t4).
This behaviour is in general concordance with the results of Ref. [13], though
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it is assumed herein that the effective COVID-19 test confirms infection with
100 % success rate on the day of the onset.
2.5 On the reliability of the COVID-19 tests
A brief review of the currently-available COVID-19 testing options may be
found in Ref. [14].
• The fastest and simplest test is the antigen-antibody/serological test. It re-
quires a few droplets of blood or serum, and targets the antibodies (im-
munoglobulin M and G) created by the organism as a response to the
COVID-19 infection. It takes about 10 min for the test to yield results,
but its accuracy is low (50− 70 %), in particular during the early phases of
the infection (not enough antibodies for detection).
• The test utilising the Polymerase Chain Reaction (RT-PCR), a method es-
tablished in the mid 1980s for the amplification of small amounts of DNA
to the level which would make a study feasible, targets the genes of the
proteins of the virus. The rRT-PCR (real-time Reverse Transcription Poly-
merase Chain Reaction) version of the test needs about 4 − 6 h to yield
results, and requires effort and facilities. Worse still, the interpretation of
the test results is not clear-cut: the diagnosis rests upon a comparison of
the outcome of each test with a threshold value (Ct value) which does not
seem to be sufficiently well-known [14]. Also relevant is the issue of what the
diagnosis would be in borderline situations, on either side of the assumed Ct
threshold. In addition, though the test is described in Ref. [14] as “highly
accurate” (97 %), recent studies [13,15] report glaring failures even on the
date of the onset of symptoms!
To reduce the probability of false negatives when using the rRT-PCRmethod,
another RT-PCR test (the Pancoronavirus RT-PCR) has been established,
first aiming at the identification of any of the Coronaviruses, then (if the
result of the first test is positive) specifically searching for COVID-19. The
test takes up to 24 h to yield results.
• The last method identifies the virus following the lengthy process of a cell
culture, and may take up to two weeks to yield results (an expedited version
of the test is also available). The test can be carried out only in strictly
controlled environments, it entails infection risks for the examiners, but it
is considered to be the most reliable at this time.
From all the above, it may be deduced that a reliable, cheap, and fast test for
COVID-19 is currently unavailable. To provide a remedy for the large amount
of false negatives (the highest risk in tests, as infective subjects are unaware
of the risk they pose to others), some authors [16] promulgate the repetitive
testing of subjects: without doubt, this might be the way to go in case of a
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cheap and fast test (e.g., of the antigen-antibody/serological test), available to
all those who need (or even wish) to be tested. Given the limited availability
of the COVID-19 tests (in comparison with the population in a country, the
number of test kits still remains small), the number of subjects who could
be repeatedly tested will inevitably have to be cut down by the number of
repetitions of the test per subject.
This section has been added for the sake of completeness. As the time instant
when an infection is confirmed is sampled herein from the [t4 − r(t4 − t1), t4]
domain, there is no room for the wrong identification of an infected subject
as uninfected (false negative). In this respect, there can be no doubt that the
quarantine durations extracted herein are on the optimistic side (i.e., smaller
than they would have been, had a more realistic approach been assumed in
relation to the effectiveness of the average COVID-19 test carried out in the
field). In practice, this realisation reinforces further the conclusions of this
work (see subsequent sections) that the shortening of the quarantine duration
is not advisable at this time.
3 Results
Nine runs were made, each generating one million travel histories using as
input:
• the duration of travel, as described in Section 2.1;
• the time instant of infection sampled from a uniform, a linear, and a loga-
rithmic distribution, as described in Section 2.2;
• the incubation interval, as described in Section 2.3; and
• the time instant when an effective COVID-19 test detects infection, as de-
scribed in Section 2.4.
In the last case, the parameter r of Section 2.4 (fraction of the incubation
interval within which the infected subject is infective) was set equal to 0.15,
0.20, and 0.25. Therefore, three choices of the distribution from which the time
instant t1 is sampled × three choices of the r value make nine runs in total.
The distribution of the duration of travel is shown in Fig. 2. The incubation
interval is sampled from the Weibull distribution displayed in Fig. B.1.
The time span between the arrival at the final destination and the time instant
when an effective COVID-19 test detects infection, i.e., t3 − t2 in Fig. 1, was
histogrammed. The simulation leaves no doubt that about half of the travellers
should be found infected before arrival at the final destination; therefore, they
should not be allowed to travel (in principle). Those who make it to the final
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Fig. 2. The distribution of the duration of travel. The histogram has been obtained
from one million generated events. The red curve is the underlying beta distribution,
rescaled to the domain between one and twenty-one days (see Section 2.1).
destination test negative (upon arrival) because (in the naive picture of Section
2.4) the viral load has not yet reached the detection level ρpos. The upper tail
of the cumulative distribution function of the time span t3 − t2 is given in
Figs. 3 (linear scale) and 4 (logarithmic scale, to allow for the details in the
right tail of the distribution to appear more clearly).
4 Discussion and conclusions
This work relates to the mitigation measure of the quarantine, imposed on
visitors to places where the probability of infection with the COVID-19 virus
is sizeable; the authorities in each country issue their own lists of such high-
risk regions. A Monte-Carlo (MC) method has been put forward, to enable
the extraction of an estimate for the minimal quarantine duration from an
analysis of the upper tail of the cumulative distribution function of the time
span between the arrival of infected subjects at the final destination and the
time when they would be found infected by an effective COVID-19 test.
A quarantine duration of eight days misses about 5 % of the infected travellers.
To be able to cut this fraction down to 1 %, a quarantine of twelve days
10
−10 −5 0 5 10 15
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
t3 − t2 (d)
1-
C
D
F
(t
3
−
t
2
)
 
 
r=0.15, linear
r=0.15, logarithmic
r=0.15, uniform
r=0.20, linear
r=0.20, logarithmic
r=0.20, uniform
r=0.25, linear
r=0.25, logarithmic
r=0.25, uniform
Fig. 3. The upper tail of the cumulative distribution function of the time span
between the arrival at the final destination and the time instant when an effective
COVID-19 test detects infection, i.e., the quantity t3 − t2 of Fig. 1. The green
horizontal solid and dashed lines mark the 5 and 1 % levels, respectively.
appears to be unavoidable. A quarantine duration of slightly over two weeks
would reduce this fraction further to about one per mille.
It must be borne in mind that the quarantine durations, given in this re-
port, are minimal: it is unlikely that an ostensibly healthy person will subject
him/herself to testing (at the right moment) before the onset of symptoms
(unless, of course, that person suspects an infection due to contacts with sub-
jects who have already been found infected). At this time, even in case that an
infected subject does decide to take the test as a precautionary measure, the
chances of a false-negative outcome do not appear to be neglectable [13,15].
The time span during which an infected subject remains infective does not
enter the present study; the quarantine durations, extracted in this work, are
independent of this quantity. This is because relevant to this study are only
the events prior to the onset of symptoms. After the appearance of symptoms,
another quarantine needs to be imposed, for a time span which (from what I
have seen in the literature) is still not sufficiently well-known.
Not considered herein are the effects induced by asymptomatic subjects. As
they have little to no indication that they have been infected, it is unlikely
that these subjects will decide to subject themselves to testing. Regarding the
11
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Fig. 4. Same as Fig. 3 for a logarithmic vertical scale.
asymptomatic subjects, relatively little is currently known. For instance, it
has not been established for how long such subjects remain infective, as well
as whether the infection probability is the same when a susceptible subject
comes into contact with a symptomatic or with an asymptomatic subject. Also
poorly known is the fraction of all infected subjects they represent: although
Ref. [17] extracted from the available data (see relevant references therein)
a population of about 17 % of all infected subjects, there have been reports
favouring significantly higher fractions.
Also not considered in this study is the impact of the quarantine duration
on the economy. Without doubt, the determination of the optimal quarantine
duration involves a difficult trade-off between its impacts on the public health,
as well as on the economic growth in each country: to find the balance point
is the challenge which most countries face at this time. My sole objection
to decisions about the quarantine duration is when they are presented to
the public as the outcome of the assessment of the former risks (impact on
health), while they have been made after also taking the latter (impact on the
economy) into account.
Provided that the distribution of the duration of travel of this work does not
significantly depart from the true one, an inescapable conclusion may be drawn
from the results of the MC simulation: the shortening of the quarantine dura-
tion, currently contemplated by the authorities in several European countries,
cannot be supported.
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Regarding the incubation interval (see Appendix B), I would be very much
interested in enhancing the database of subjects. I would also welcome data
on the distribution of the duration of travels from reliable sources. I am inter-
ested in mixed samples: no gender/age/nationality discrimination, including
all types of travels (professional/recreational) and (ultimately) all means of
transport.
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A On fitting probability density functions with infinite support to
histogram data
Let f(x) be a probability density function (PDF) of the real variable x ∈ R>0.
Examples of such distributions are the three which are routinely employed
in Epidemiology: gamma, log-normal, and Weibull. The purpose of this ap-
pendix is to outline a meaningful procedure for extracting estimates for the
parameters of such distributions from histogram data extending from x = 0
to xu, arranged in n histogram bins. The content of the histogram bin i for
1 ≤ i ≤ n will be denoted by Ni.
Frequently in studies, the various PDF forms are directly fitted to the prob-
abilities p˜i := Ni/N , where N =
∑n
i=1Ni. This approach is problematic for
three reasons:
a) the departure of f(x) from linearity within each histogram bin is neglected;
b) there is an evident dependence of the results on the bin size of the histogram;
and
c) the approach takes no account of the fact that the PDF has infinite sup-
port (whereas xu, being the largest right-hand endpoint, obviously remains
finite).
To remedy the first two drawbacks, the fitted probability pfi should be obtained
as the difference of the corresponding cumulative distribution function (CDF)
at the two endpoints ai and bi of the histogram bin i:
pfi =
∫ bi
ai
f(x)dx . (A.1)
To remedy the third drawback, a correction needs to be applied to the his-
togram data, taking account of the fact that the integral
α :=
∫
∞
xu
f(x)dx > 0 . (A.2)
In other words, the true probabilities pi differ from p˜i, in that they should in-
volve not only the sum of the observations N , but also the contributions to the
distribution from the infinite interval x > xu, i.e., from existing observations
which have been omitted (e.g., because they are sparse) or which did not find
their way to the database (e.g., due to limited statistics); whether the data
has been right-censored or right-truncated is of no relevance. In practice, N
must be replaced by N/(1−α) when assigning a probability to the histogram
bin i:
p˜i :=
Ni
N
→ pi :=
Ni
N
∞
=
(1− α)Ni
N
= (1− α)p˜i . (A.3)
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The quantities pi are the true probabilities, to be compared in the optimisation
with pfi of Eq. (A.1). Following from the binomial distribution, the uncertainty
δpi of the true probability pi is obtained via the formula:
δpi =
√
pi(1− pi)
N
∞
= (1− α)
√
p˜i (1− p˜i(1− α))
N
. (A.4)
Therefore, the true probabilities pi and their uncertainties δpi can be evaluated
from the observations Ni and from the upper tail α of the CDF.
When a χ2 minimisation function is used in the optimisation, the following
formula applies:
χ2 = N
n∑
i=1
(
p˜i − p
f
i /(1− α)
)2
p˜i (1− p˜i(1− α))
. (A.5)
For large values of xu, α → 0, and Eq. (A.5) reduces to the better-known
formula
χ2 = N
n∑
i=1
(
p˜i − p
f
i
)2
p˜i (1− p˜i)
. (A.6)
However, Eq. (A.5) makes no assumptions about the largeness of xu and should
be used when fitting PDFs with infinite support to histogram data. The quan-
tity α is obtained at each step of the optimisation from the parameters of the
corresponding distribution.
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B The extraction of the distribution of the incubation interval
from available data
To the best of my knowledge, seventeen peer-reviewed studies have reported
on the incubation interval. Eight of these works [20,21,22,23,24,25,26,27] have
made the details of their data publicly available. The details of the data, used
in one additional study [18], were also communicated to me by the first author.
My efforts notwithstanding, it has not been possible to enhance the database
further by also including the data of the remaining eight studies.
From the 996 available subjects, selected were those with complete data re-
garding the exposure window (i.e., the start and the end dates of the exposure
interval), as well as the date corresponding to the onset of symptoms. Only one
correction was applied: if the date on which the onset of symptoms preceded
the one corresponding to the end of the exposure window, then the latter
was set equal to the former. The maximal incubation interval, admitted to
the analysis, was 25 days. (As there is no subject with a maximal incubation
interval of 24 days, that quantity was reset - automatically in the software ap-
plication - to 24 days.) A contribution from each subject to the distribution of
the incubation interval, inversely proportional to the duration of the exposure
window, was appended to the contents of the histogram bins contained within
that window. Evidently, assumed was a uniform distribution of the probability
of infection within each exposure window.
After applying the corrections 1 outlined in Appendix A, the data was submit-
ted to a χ2-based optimisation, utilising three standard distributions: gamma,
log-normal, and Weibull. As two free parameters enter these distributions,
there are 22 degrees of freedom (DoFs) in each fit. It was found that the
results, obtained with the log-normal distribution, are not as good as those
extracted with the other two distributions: with a p-value barely over 1 %
(namely, 1.17 · 10−2), the log-normal distribution strives to accommodate the
(relatively short) tail of the observed distribution of the incubation interval.
On the other hand, the data is well described by the gamma and Weibull
distributions. The fitted values and uncertainties of the parameters of these
two distributions are detailed in Table B.1. A plot of the data, along with the
fitted values in case of the gamma and Weibull fits, is shown in Fig. B.1.
There have been reports in the literature of longer (mean/median) incubation
intervals than those appearing in Table B.1 of this work. Several of those val-
ues have been obtained after including in the analysis subjects with partially-
known exposure windows, e.g., subjects with unknown start date of the ex-
posure. To accommodate such subjects in the sample and gain in statistics,
1 These corrections are negligible for the distribution dealt with in this section: in
case of the Weibull fit, α ≈ 6.43 · 10−5; in case of the gamma fit, α ≈ 8.69 · 10−4.
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Table B.1
Fitted values and uncertainties of the parameters of the gamma and Weibull dis-
tributions, as they come out of the fit to the incubation-interval data from 516
subjects with known details about the exposure window and the date of the onset
of symptoms [18,20,21,22,23,24,25,26,27]. Shown are the results obtained from two
(equivalent) modelling options in each case: the mean and rms of the two aforemen-
tioned distributions may be expressed in terms of the shape and scale parameters,
and vice versa. The median in case of the fit using the Weibull distribution is about
five days. The two scale parameters, as well as the means and the rms’s of the
distributions, are expressed in days.
Distribution Parameter Fitted results Parameter Fitted results
Standard parameterisation
Gamma Shape a 2.41+0.18
−0.16 Scale b (d) 2.35
+0.18
−0.17
Weibull Shape k 1.675+0.066
−0.062 Scale λ (d) 6.20 ± 0.17
Parameterisation using the mean and the rms of the distribution
Gamma Mean (d) 5.64 ± 0.15 rms (d) 3.64+0.16
−0.15
Weibull Mean (d) 5.54 ± 0.15 rms (d) 3.40 ± 0.15
assumptions need to be made about their most probable time instant of in-
fection. I suspect that the larger values of the incubation interval, obtained in
those works, are due to assumptions about the distribution of the probability
of infection in an infinite (in principle) exposure window. On the contrary,
as only subjects with well-known details have contributed to the distribution
shown in Fig. B.1, this work rests upon no such assumptions.
Regarding the comparison of results, obtained in several studies from different
modelling options of the same data, I have one comment. Many authors favour
modelling options on the basis of the application of the Akaike information
criterion (AIC) [28]. My stand is that such complexity is entirely uncalled
for in the problem dealt with in this section. In case of normally-distributed
residuals, the maximisation of the likelihood is mathematically equivalent to
the minimisation of the χ2 function. When the different modelling options
make use of the same number of parameters to fit the same data, the resulting
value of the AIC score is bound to be equal to the χ2min value plus a constant!
Several authors select the modelling option with the minimal AIC score, but
refrain from addressing the significance of that choice. Well, yes, there will
always be one modelling option which yields a better result. However, is that
result significantly different to the second best?
There is only one established method (which I am aware of) for addressing
the significance of the difference between two results obtained via a χ2-based
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Fig. B.1. The distribution of the incubation interval, obtained from 516 subjects
with known details about the exposure window and the date of the onset of
symptoms. The database was created from the publicly-available details given in
Refs. [20,21,22,23,24,25,26,27], as well as from one set communicated to me by the
first author of Ref. [18].
method: it involves Fisher’s (F ) distribution. If the two results are: χ21 with ν1
DoFs and χ22 with ν2 DoFs, where χ
2
1/ν1 > χ
2
2/ν2, one first evaluates the ratio
u =
χ21/ν1
χ22/ν2
. (B.1)
The quantity u follows the F distribution with ν1 and ν2 DoFs. In case of
the incubation data of this section, the application of the AIC criterion would
result in a difference of about 2.2 between the gamma and the Weibull fits.
On the basis of this score, many authors would probably hasten to consider
the Weibull fit ‘superior’. However, the u score of about 1.28 for 22 and 22
DoFs yields the p-value of about 2.86 · 10−1, hence no indication that the fit
quality is significantly different in the two cases.
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